Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution

BACKGROUND/AIMS: Glecaprevir/pibrentasvir (G/P) is a combination of direct-acting antiviral agents that is an approved treatment for chronic infections by all six hepatitis C virus (HCV) genotypes. However, there are limited data on the effect of G/P in Korean patients in actual real-world settings....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gut Liver
Main Authors: Park, Young Joo, Woo, Hyun Young, Heo, Jeong, Park, Sang Gyu, Hong, Young Mi, Yoon, Ki Tae, Kim, Dong Uk, Kim, Gwang Ha, Kim, Hyung Hoi, Song, Geun Am, Cho, Mong
Formato: Artigo
Idioma:Inglês
Publicado em: Editorial Office of Gut and Liver 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129668/
https://ncbi.nlm.nih.gov/pubmed/32839365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19393
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados